Variable Rate [Domain] Variable Rate [Domain] Schedule of Accrued and Other Current Liabilities Schedule of Accrued Liabilities [Table Text Block] Accrued and other current liabilities Accrued and other current liabilities Accrued Liabilities, Current Statistical Measurement [Domain] Statistical Measurement [Domain] Research and development expenses Research and Development Expense Changes in assets and liabilities: Increase (Decrease) in Operating Capital [Abstract] Stock options, expiration period Share-Based Compensation Arrangement by Share-Based Payment Award, Expiration Period Accrued royalties Accrued Royalties, Current Innovatus Life Sciences Lending Fund Innovatus Life Sciences Lending Fund [Member] Innovatus Life Sciences Lending Fund Award Type [Domain] Award Type [Domain] Outstanding, beginning of period (in shares) Outstanding, end of period (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number Borrowings Debt Disclosure [Text Block] Statement of Stockholders' Equity [Abstract] Statement of Stockholders' Equity [Abstract] Research and Development Research and Development Expense, Policy [Policy Text Block] Number of monthly installments Debt Instrument, Number Of Monthly Installments Debt Instrument, Number Of Monthly Installments Accounts payable Accounts Payable, Current Commitments and contingencies Commitments and Contingencies Supplier [Axis] Supplier [Axis] Disaggregation of Revenue [Line Items] Disaggregation of Revenue [Line Items] Stockholders' Equity Equity [Text Block] Vested and expected to vest, Aggregate Intrinsic Value Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value Blue Shield Blue Shield [Member] Blue Shield Other assets Increase (Decrease) in Other Noncurrent Assets Collaborative Arrangement and Arrangement Other than Collaborative [Axis] Collaborative Arrangement and Arrangement Other than Collaborative [Axis] Proceeds from common stock issued under Employee Stock Purchase Plan Proceeds from Stock Plans Royalty obligation, percent of net sales Royalty Obligation, Percentage of Sales Royalty Obligation, Percentage of Sales Total property and equipment Property, Plant, and Equipment and Finance Lease Right-of-Use Asset, before Accumulated Depreciation and Amortization Revenue Recognition Revenue [Policy Text Block] Customer [Axis] Customer [Axis] Current liabilities: Liabilities, Current [Abstract] Par value (in dollars per share) Preferred Stock, Par or Stated Value Per Share Preferred stock, $0.001 par value; 10,000,000 shares authorized, no shares issued or outstanding as of June 30, 2023 and December 31, 2022 Preferred Stock, Value, Issued Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract] Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract] Net loss per share, diluted (in dollars per share) Earnings Per Share, Diluted Property, Plant and Equipment [Table] Property, Plant and Equipment [Table] Accounts receivable, net Accounts Receivable, after Allowance for Credit Loss, Current Refund liability Customer Refund Liability, Current Supplemental disclosure of non-cash items: Supplemental Cash Flow Elements [Abstract] Vested and expected to vest, end of period (in shares), Weighted Average Exercise Price (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price Level 3 Fair Value, Inputs, Level 3 [Member] Outstanding, beginning of period (in shares) Outstanding, end of period (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number Exercise of stock options Stock Issued During Period, Value, Stock Options Exercised Trading Symbol Trading Symbol Granted, Weighted Average Exercise Price (in dollars per share) Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price Net loss Net loss Net Income (Loss) Total current liabilities Liabilities, Current Paid in-kind note Payment in Kind (PIK) Note [Member] Fair Value Disclosures [Abstract] New Accounting Pronouncement, Early Adoption [Table] Accounting Standards Update and Change in Accounting Principle [Table] Accrued purchases of goods and services Accrued Purchase, Goods and Services, Current Accrued Purchase, Goods and Services, Current Schedule of Cash and Cash Equivalents Schedule of Cash and Cash Equivalents [Table Text Block] Accrued interest Interest Payable, Current Property and equipment, net Property and equipment, net Property, Plant, and Equipment and Finance Lease Right-of-Use Asset, after Accumulated Depreciation and Amortization Liabilities and Stockholders' Equity Liabilities and Equity [Abstract] Entity Ex Transition Period Entity Ex Transition Period Employee stock purchase plan Employee Stock [Member] Stockholders' equity: Equity, Attributable to Parent [Abstract] Concentration Risk Benchmark [Domain] Concentration Risk Benchmark [Domain] Exercise of stock options (in shares) Exercised (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period Costs of revenue Cost of Goods and Services Sold Term loan, paid in-kind loans issued Debt Instrument, Paid In Kind Loans Issued Debt Instrument, Paid In Kind Loans Issued Stock options, vesting period Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period Comprehensive Loss Comprehensive Income, Policy [Policy Text Block] Warrant expiration September 7, 2024 Expiration Sep 7, 2024 [Member] Expiration Sep 7, 2024 Notes payable, noncurrent Notes Payable, Noncurrent New Accounting Pronouncement, Early Adoption [Line Items] New Accounting Pronouncements or Change in Accounting Principle [Line Items] Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward] Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward] Summary of Significant Accounting Policies Significant Accounting Policies [Text Block] Exercised, Weighted Average Exercise Price (in dollars per share) Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price Level 1 Fair Value, Inputs, Level 1 [Member] Schedule of Property and Equipment Property, Plant and Equipment [Table Text Block] Equity Components [Axis] Equity Components [Axis] Class of warrant or right, exercise price of warrants or rights (in dollars per share) Class of Warrant or Right, Exercise Price of Warrants or Rights Financial Instruments [Domain] Financial Instruments [Domain] Certificate of deposit, included in cash and cash equivalents Certificates of Deposit [Member] Shares that remain available for future awards (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Available for Grant 2025 Long-Term Debt, Maturity, Year Two Granted (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross Entity Small Business Entity Small Business Warrant expiration March 31, 2026 Expiration Mar 31, 2026 [Member] Expiration Mar 31, 2026 Local Phone Number Local Phone Number Accounts receivable, net Increase (Decrease) in Accounts Receivable Selling, general and administrative Selling, General and Administrative Expenses [Member] 2023 (remaining) Long-Term Debt, Maturity, Remainder of Fiscal Year Accounts Receivable Accounts Receivable [Member] Measurement Frequency [Axis] Measurement Frequency [Axis] Warrants to purchase common stock Warrant [Member] Non-current operating lease liabilities Operating Lease, Liability, Noncurrent Restricted stock units Restricted Stock Units (RSUs) [Member] Fair Value Measurement Inputs and Valuation Techniques [Table] Fair Value Measurement Inputs and Valuation Techniques [Table] Debt Instrument, Name [Domain] Debt Instrument, Name [Domain] Medicare Medicare [Member] Medicare Income Statement Location [Axis] Income Statement Location [Axis] Collaborative Arrangement and Arrangement Other than Collaborative [Domain] Collaborative Arrangement and Arrangement Other than Collaborative [Domain] Unamortized debt discount and issuance costs Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net Warrant expiration December 7, 2025 Expiration Dec 7, 2025 [Member] Expiration Dec 7, 2025 Cash, Cash Equivalents and Restricted Cash Cash and Cash Equivalents, Policy [Policy Text Block] Shipping and Handling Costs Cost of Goods and Service [Policy Text Block] Product and Service [Domain] Product and Service [Domain] Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block] Prepaid expenses and other current assets Increase (Decrease) in Prepaid Expense and Current Other Assets Increase (Decrease) in Prepaid Expense and Current Other Assets Research and development Research and Development Expense [Member] Common stock Common Stock, Number of Shares, Par Value and Other Disclosure [Abstract] Anti-dilutive securities excluded from computation (in shares) Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount Award Type [Axis] Award Type [Axis] Awards granted (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period Plan Name [Domain] Plan Name [Domain] Document Quarterly Report Document Quarterly Report Prepayment of principal Payment for Debt Extinguishment or Debt Prepayment Cost Interest expense Interest Expense Costs incurred, but not paid, in connection with capital expenditures Capital Expenditures Incurred but Not yet Paid Fair Value Hierarchy and NAV [Domain] Fair Value Hierarchy and NAV [Domain] Outstanding, Weighted Average Remaining Contractual Term Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term Long-term Debt, Type [Domain] Long-Term Debt, Type [Domain] Settlement charge Loss Contingency, Loss in Period Entity File Number Entity File Number Loss Contingencies [Table] Loss Contingencies [Table] Schedule of Restricted Stock Unit Activity Share-Based Payment Arrangement, Restricted Stock Unit, Activity [Table Text Block] Operating lease liabilities Operating Lease, Liability, Current 2026 Long-Term Debt, Maturity, Year Three Issuance of stock under Employee Stock Purchase Plan (in shares) Stock Issued During Period, Shares, Employee Stock Purchase Plans Entity Shell Company Entity Shell Company Debt instrument, minimum cash balance Debt Instrument, Minimum Cash Balance Required, Not Required To Comply With Covenant Debt Instrument, Minimum Cash Balance Required, Not Required To Comply With Covenant Property, Plant and Equipment [Line Items] Property, Plant and Equipment [Line Items] Recent Accounting Pronouncements and Recently Adopted Accounting Standards New Accounting Pronouncements, Policy [Policy Text Block] Counterparty Name [Domain] Counterparty Name [Domain] Cash, cash equivalents and restricted cash, beginning of period Cash, cash equivalents and restricted cash, end of period Total cash, cash equivalents and restricted cash Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents Debt instrument Debt Instrument, Fair Value Disclosure Loan payable Loans Payable [Member] Prometheus Laboratories Prometheus Laboratories, Inc. [Member] Prometheus Laboratories, Inc. Long-lived Assets Impairment or Disposal of Long-Lived Assets, Policy [Policy Text Block] Shares issued (in shares) Common Stock, Shares, Issued Awards released (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period Security Exchange Name Security Exchange Name Total Assets, Fair Value Disclosure Long-term debt Total borrowings, net of discounts and debt issuance costs Long-Term Debt Stock-Based Compensation Share-Based Payment Arrangement [Policy Text Block] Proceeds from sale of stock Sale of Stock, Consideration Received on Transaction Selling, general and administrative expenses Selling, General and Administrative Expense 2019 Incentive Award Plan Incentive Award Plan, 2019 [Member] Incentive Award Plan, 2019 Stock options Employee Stock Option [Member] Stock options, cost not yet recognized, remaining weighted average vesting period Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition Total operating expenses Costs and Expenses Interest Long-term Debt, Undiscounted Interest Amount Long-term Debt, Undiscounted Interest Amount Maximum Maximum [Member] Stock options, unrecognized compensation cost Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount Document Type Document Type Aggregate intrinsic value, vested Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Aggregate Intrinsic Value, Vested Entity Address, Address Line One Entity Address, Address Line One Antidilutive Securities, Name [Domain] Antidilutive Securities, Name [Domain] Term loan, paid in-kind, interest rate Debt Instrument, Stated Interest Rate, Paid In-Kind Debt Instrument, Stated Interest Rate, Paid In-Kind Stock Option Plan Share-Based Payment Arrangement [Text Block] Issuance of stock from vested restricted stock units and payment of employees' taxes (in shares) Issuance Of Stock From Vested Restricted Stock Units And Payment Of Employees Taxes, Shares Issuance Of Stock From Vested Restricted Stock Units And Payment Of Employees Taxes, Shares Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract] Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract] Maximum employee payroll deduction percentage Share-Based Compensation Arrangement by Share-Based Payment Award, Maximum Employee Subscription Rate Customer Concentration Risk Customer Concentration Risk [Member] Preferred stock Preferred Stock, Number of Shares, Par Value and Other Disclosure [Abstract] Variable Rate [Axis] Variable Rate [Axis] Income Statement [Abstract] Income Statement [Abstract] Other Other Customer [Member] Operating expenses: Costs and Expenses [Abstract] Forfeited (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures in Period Title of 12(b) Security Title of 12(b) Security Money market funds, included in cash and cash equivalents Cash and Cash Equivalents, Fair Value Disclosure Prepaid maintenance and insurance contracts Prepaid Maintenance and Insurance Contracts Prepaid Maintenance and Insurance Contracts Outstanding, beginning of period (in dollars per share) Outstanding, end of period (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value Diagnostic testing supplies Other Assets, Current Class of Stock [Line Items] Class of Stock [Line Items] Share-Based Payment Arrangement [Abstract] Entity Tax Identification Number Entity Tax Identification Number Statistical Measurement [Axis] Statistical Measurement [Axis] Financial Instrument [Axis] Financial Instrument [Axis] Entity Interactive Data Current Entity Interactive Data Current Collaboration agreement, collaboration expenses Collaboration Agreement, Collaboration Expenses Collaboration Agreement, Collaboration Expenses Disaggregation of Revenue [Table] Disaggregation of Revenue [Table] Advertising and Marketing Costs Advertising Cost [Policy Text Block] Future minimum royalty commitment Royalty Guarantees, Commitments, Amount Commercial Healthcare Insurers [Member] Healthcare Insurers Entity Common Stock, Shares Outstanding (in shares) Entity Common Stock, Shares Outstanding Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Aggregate Intrinsic Value [Abstract] Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Aggregate Intrinsic Value [Abstract] Share-based Compensation Arrangement by Share-based Payment Award [Line Items] Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] Fair Value Hierarchy and NAV [Axis] Fair Value Hierarchy and NAV [Axis] Aetna Aetna [Member] Aetna Accumulated deficit Retained Earnings (Accumulated Deficit) Commitments and Contingencies Disclosure [Abstract] Entity Incorporation, State or Country Code Entity Incorporation, State or Country Code Current assets: Assets, Current [Abstract] Advertising expense Advertising Expense Entity Address, State or Province Entity Address, State or Province Counterparty Name [Axis] Counterparty Name [Axis] Class of Warrant or Right [Domain] Class of Warrant or Right [Domain] Purchase obligation, due in year one Purchase Obligation, to be Paid, Year One Shares outstanding (in shares) Beginning balance (in shares) Ending balance (in shares) Common Stock, Shares, Outstanding Exercise of common stock warrants (in shares) Stock Issued During Period, Shares, Warrants Exercised, Net Stock Issued During Period, Shares, Warrants Exercised, Net Concentration of Credit Risk and Other Risk and Uncertainties Concentration Risk, Credit Risk, Policy [Policy Text Block] Notes payable Notes Payable Par value (in dollars per share) Common Stock, Par or Stated Value Per Share Sale of Stock [Axis] Sale of Stock [Axis] Computer equipment and software Computer Equipment and Software [Member] Computer Equipment and Software Net cash used in investing activities Net Cash Provided by (Used in) Investing Activities Customer [Domain] Customer [Domain] Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward] Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding [Roll Forward] Debt Instrument [Axis] Debt Instrument [Axis] Options exercisable, Aggregate Intrinsic Value Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Exercisable, Aggregate Intrinsic Value Prepaid product royalties Prepaid Royalties Schedule of Future Minimum Aggregate Payments for Outstanding Borrowings Schedule of Maturities of Long-Term Debt [Table Text Block] Total liabilities Liabilities Options exercised, end of period (in shares), Weighted Average Exercise Price (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Exercise Price Measurement Frequency [Domain] Measurement Frequency [Domain] Plan Name [Axis] Plan Name [Axis] Allegheny Health Network Research Institute Allegheny Health Network Research Institute [Member] Allegheny Health Network Research Institute Debt Disclosure [Abstract] Property, Plant and Equipment, Type [Domain] Long-Lived Tangible Asset [Domain] Common stock, $0.001 par value; 200,000,000 shares authorized as of June 30, 2023 and December 31, 2022; 16,858,194 and 16,549,984 shares issued and outstanding as of June 30, 2023 and December 31, 2022, respectively Common Stock, Value, Issued Organization, Consolidation and Presentation of Financial Statements [Abstract] Legal accrual Accrued Professional Fees, Current 2017 Term loan Term 2017 [Member] Term 2017 Segment Reporting Segment Reporting, Policy [Policy Text Block] Total current assets Assets, Current Principal payments on finance lease obligations Finance Lease, Principal Payments Restricted cash Restricted Cash Schedule of Concentration of Risk, by Risk Factor and Significant Payer Schedules of Concentration of Risk, by Risk Factor [Table Text Block] Supplemental disclosure of cash flow information: Supplemental Cash Flow Information [Abstract] Other income, net Other Nonoperating Income (Expense) Entity Filer Category Entity Filer Category Depreciation and amortization Cost, Depreciation and Amortization Statement [Table] Statement [Table] Current Fiscal Year End Date Current Fiscal Year End Date Net Loss Per Share Earnings Per Share, Policy [Policy Text Block] Term loan, covenant, number of days to cure covenant if performance measure is not met Debt Instrument, Covenant, Number Of Days To Cure If Performance Measure Is Not Met Debt Instrument, Covenant, Number Of Days To Cure If Performance Measure Is Not Met Percent of total revenue Concentration Risk, Percentage Warrants issued to purchase redeemable convertible preferred stock (in shares) Class of Warrant or Right, Outstanding Shares authorized (in shares) Preferred Stock, Shares Authorized Weighted-average grant date fair value (in dollars per share) Awards granted, Weighted-Average Grant Date Fair Value (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value Expired (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Expirations in Period Shares outstanding (in shares) Preferred Stock, Shares Outstanding Schedule of Prepaid Expenses and Other Current Assets Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Table Text Block] Net cash used in operating activities Net Cash Provided by (Used in) Operating Activities Intrinsic value Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Intrinsic Value Other accrued liabilities Other Accrued Liabilities, Current Product Concentration Risk Product Concentration Risk [Member] Term loan, fee incurred upon payment of final installment Debt Instrument, Fee Amount Accrued payroll and related expenses Accrued Salaries, Current Depreciation and amortization Depreciation, Depletion and Amortization Furniture and fixtures Furniture and Fixtures [Member] Term loan, interest rate Debt Instrument, Interest Rate, Stated Percentage Statement of Financial Position [Abstract] Statement of Financial Position [Abstract] Total stockholders' equity Beginning balance Ending balance Equity, Attributable to Parent Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table] Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table] Revenue recognized in previous periods Contract with Customer, Liability, Revenue Recognized AHN Collaboration AHN Collaboration [Member] AHN Collaboration Schedule of Stock by Class [Table] Schedule of Stock by Class [Table] Concentration Risk Type [Axis] Concentration Risk Type [Axis] Fair Value Measurements Fair Value Measurement, Policy [Policy Text Block] Property, Plant and Equipment, Type [Axis] Long-Lived Tangible Asset [Axis] Shares issued (in shares) Preferred Stock, Shares Issued Level 2 Fair Value, Inputs, Level 2 [Member] Entity Emerging Growth Company Entity Emerging Growth Company Term loan covenant, minimum unrestricted cash balance Debt Instrument, Covenant Compliance, Minimum Unrestricted Cash Balance Debt Instrument, Covenant Compliance, Minimum Unrestricted Cash Balance Term loan, effective interest rate Debt Instrument, Interest Rate, Effective Percentage Increase (Decrease) in Stockholders' Equity [Roll Forward] Increase (Decrease) in Stockholders' Equity [Roll Forward] Document Fiscal Period Focus Document Fiscal Period Focus Remaining borrowing capacity Line of Credit Facility, Remaining Borrowing Capacity Accrued and other current liabilities Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities Antidilutive Securities [Axis] Antidilutive Securities [Axis] Outstanding, beginning of period, Weighted Average Exercise Price (in dollars per share) Outstanding, end of period, Weighted Average Exercise Price (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price Stock-based compensation Share-Based Payment Arrangement, Noncash Expense Non-cash interest expense Paid-in-Kind Interest Common Stock Common Stock [Member] City Area Code City Area Code Entity Address, Postal Zip Code Entity Address, Postal Zip Code Two Major Suppliers Two Major Suppliers [Member] Two Major Suppliers Product and Service [Axis] Product and Service [Axis] Income Statement Location [Domain] Income Statement Location [Domain] Government Government1 [Member] Government1 Document Fiscal Year Focus Document Fiscal Year Focus Supplier [Domain] Supplier [Domain] Equipment purchased under notes payable obligations Equipment Purchased Under Notes Payable Obligations Equipment Purchased Under Notes Payable Obligations Minimum Minimum [Member] Organization Organization, Consolidation, Basis of Presentation, Business Description and Accounting Policies [Text Block] Schedule of Stock Option Activity Share-Based Payment Arrangement, Option, Activity [Table Text Block] Schedule of Outstanding Warrants Schedule of Stockholders' Equity Note, Warrants or Rights [Table Text Block] Statement of Cash Flows [Abstract] Statement of Cash Flows [Abstract] Assets Assets [Abstract] Term loan borrowings Proceeds from Issuance of Long-Term Debt Operating lease liabilities Increase (Decrease) in Operating Lease Liability Other Financial Information Prepaid Expenses and Other Current Assets; Property, Plant and Equipment; and Accrued Liabilities [Text Block] Prepaid Expenses and Other Current Assets; Property, Plant and Equipment; and Accrued Liabilities Payments of taxes withheld on vested restricted stock units Payment, Tax Withholding, Share-Based Payment Arrangement Cash flows from financing activities: Net Cash Provided by (Used in) Financing Activities, Continuing Operations [Abstract] Net cash used in financing activities Net Cash Provided by (Used in) Financing Activities Commitments and Contingencies Commitments and Contingencies Disclosure [Text Block] Accumulated Deficit Retained Earnings [Member] Borrowings-current portion Less: Borrowings-current portion Long-Term Debt, Current Maturities Schedule of Non-cash Stock-based Compensation Expense Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block] Total liabilities and stockholders' equity Liabilities and Equity Other assets Other Assets, Noncurrent Research and Development Arrangement, Contract to Perform for Others, Type [Domain] Research and Development Arrangement, Contract to Perform for Others, Type [Domain] Net loss per share, basic (in dollars per share) Earnings Per Share, Basic Operating lease right-of-use assets Operating Lease, Right-of-Use Asset Schedule of Long-term Debt Instruments [Table] Schedule of Long-Term Debt Instruments [Table] Issuance of stock under Employee Stock Purchase Plan Stock Issued During Period, Value, Employee Stock Purchase Plan Common stock options Equity Option [Member] Accounting Policies [Abstract] Sale of Stock [Domain] Sale of Stock [Domain] Loss on disposal of assets Gain (Loss) on Disposition of Assets Medicare Advantage Medicare Advantage [Member] Medicare Advantage Term loan, covenant, revenue performance period Debt Instrument, Covenant, Revenue Performance Period Debt Instrument, Covenant, Revenue Performance Period Entity Address, City or Town Entity Address, City or Town Schedule of Restricted Cash and Cash Equivalents Restrictions on Cash and Cash Equivalents [Table Text Block] Term loan, prepayment premium percentage Debt Instrument, Prepayment Premium Percentage Debt Instrument, Prepayment Premium Percentage Purchase obligation, due in second year Purchase Obligation, to be Paid, Year Two Vested and expected to vest, Weighted Average Remaining Contractual Term Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Remaining Contractual Term Options exercisable, end of period (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Exercisable, Number Purchase obligation, due in third year Purchase Obligation, to be Paid, Year Three Cash flows from investing activities: Net Cash Provided by (Used in) Investing Activities, Continuing Operations [Abstract] Document Transition Report Document Transition Report Accounts payable Increase (Decrease) in Accounts Payable Shares authorized (in shares) Common Stock, Shares Authorized Advance royalties payment Advance Payment Advance Payment Line of Credit Facility, Lender [Domain] Line of Credit Facility, Lender [Domain] Adjustments to reconcile net loss to net cash used in operating activities: Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract] Supplier Concentration Risk Supplier Concentration Risk [Member] Notes payable, current Notes Payable, Current Non-cash lease expense Non-Cash Lease Expense Non-Cash Lease Expense Less: accumulated depreciation and amortization Property, Plant, and Equipment and Finance Lease Right-of-Use Asset, Accumulated Depreciation and Amortization AVISE CTD Test AVISE CTD Test [Member] AVISE CTD Test Additional paid-in capital Additional Paid in Capital Research and Development Arrangement, Contract to Perform for Others, Type [Axis] Research and Development Arrangement, Contract to Perform for Others, Type [Axis] Laboratory equipment Laboratory Equipment [Member] Laboratory Equipment Awards canceled, Weighted-Average Grant Date Fair Value (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value Proceeds from exercise of stock options Proceeds from Stock Options Exercised Warrant expiration January 19, 2026 Expiration Jan 19, 2026 [Member] Expiration Jan 19, 2026 Forfeited, Weighted Average Exercise Price (in dollars per share) Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price Prepaid expenses and other current assets Prepaid Expense and Other Assets, Current Outstanding, Aggregate Intrinsic Value Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Aggregate Intrinsic Value, Outstanding Awards canceled (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeited in Period Other Long Term Debt Other Long Term Debt [Member] Other Long Term Debt 2024 Long-Term Debt, Maturity, Year One Outstanding, Aggregate Intrinsic Value Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value Equipment Notes Payable Equipment Notes Payable [Member] Equipment Notes Payable Entity Registrant Name Entity Registrant Name Term loan, annual reduction in prepayment penalty percentage Debt Instrument, Prepayment Premium Percentage, Annual Reduction Debt Instrument, Prepayment Premium Percentage, Annual Reduction Accrued clinical study activity Accrued Liabilities, Clinical Study, Current Accrued Liabilities, Clinical Study, Current Proceeds from disposal of property and equipment Proceeds from Sale of Property, Plant, and Equipment Costs of revenue Cost of Sales [Member] Document Period End Date Document Period End Date Term loan covenant, increase to interest rate Debt Instrument, Covenant Non-Compliance, Interest Rate, Increase (Decrease) Debt Instrument, Covenant Non-Compliance, Interest Rate, Increase (Decrease) Schedule of Fair Value, Financial Instrument Measured on a Recurring Basis Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block] Principal payment on long-term debt Repayments of Long-Term Debt Entity Central Index Key Entity Central Index Key Amortization of debt discount and debt issuance costs Amortization of Debt Issuance Costs and Discounts No expiration No expiration [Member] No expiration Class of Warrant or Right [Axis] Class of Warrant or Right [Axis] Stock-based compensation expense Share-Based Payment Arrangement, Expense Client Client [Member] Client Fair Value Measurements Fair Value Disclosures [Text Block] Licensing Agreements License Agreement Terms [Member] Number of operating segments Number of Operating Segments Revenue Revenue Benchmark [Member] Schedule of Disaggregation of Revenue Disaggregation of Revenue [Table Text Block] Lender Name [Axis] Lender Name [Axis] Equity [Abstract] Revenue Revenue from Contract with Customer, Excluding Assessed Tax Long-term Debt, Type [Axis] Long-Term Debt, Type [Axis] Amendment Flag Amendment Flag Money market funds, included in cash and cash equivalents Money Market Funds [Member] Total Long-term Debt, Including Undiscounted Interest Long-term Debt, Including Undiscounted Interest Cash and cash equivalents Cash and cash equivalents Cash and Cash Equivalents, at Carrying Value Principal payment on note payable obligations Repayments of Notes Payable Collaboration fee Collaboration Agreement, Annual Collaboration Fee Collaboration Agreement, Annual Collaboration Fee Other Financial Information [Abstract] Other Financial Information Cash paid for interest Interest Paid, Excluding Capitalized Interest, Operating Activities Assets: Assets, Fair Value Disclosure [Abstract] Variable rate Debt Instrument, Basis Spread on Variable Rate Borrowings-non-current portion, net of discounts and debt issuance costs Borrowings-non-current portion, net of discounts and debt issuance costs Long-Term Debt, Excluding Current Maturities Leasehold improvements Leasehold Improvements [Member] Weighted-average number of shares used to compute net loss per share, diluted (in shares) Weighted Average Number of Shares Outstanding, Diluted Equipment purchased under finance lease obligations Right-of-Use Asset Obtained in Exchange for Finance Lease Liability Purchases of property and equipment Payments to Acquire Property, Plant, and Equipment Additional Paid-In Capital Additional Paid-in Capital [Member] Expired, Weighted Average Exercise Price (in dollars per share) Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price Total assets Assets Cowen Equity Distribution Agreement Cowen Equity Distribution Agreement [Member] Cowen Equity Distribution Agreement Loss Contingencies [Line Items] Loss Contingencies [Line Items] Cover [Abstract] Options exercisable, Weighted Average Remaining Contractual Term Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Remaining Contractual Term Stock-based compensation APIC, Share-Based Payment Arrangement, Increase for Cost Recognition Other prepaid expenses and other current assets Other Prepaid Expense, Current Shares authorized, percentage Share-based Compensation Arrangement by Share-based Payment Award, Additional Shares Authorized, Percentage Share-based Compensation Arrangement by Share-based Payment Award, Additional Shares Authorized, Percentage Recurring Fair Value, Recurring [Member] Fair Value Measurement Inputs and Valuation Techniques [Line Items] Fair Value Measurement Inputs and Valuation Techniques [Line Items] Other non-current liabilities Other Liabilities, Noncurrent Awards released, Weighted-Average Grant Date Fair Value (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value Construction in progress Construction in Progress [Member] Warrant expiration April 1, 2026 Expiration Apr 1, 2026 [Member] Expiration Apr 1, 2026 Prime Rate Prime Rate [Member] Net change in cash, cash equivalents and restricted cash Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect Equity Component [Domain] Equity Component [Domain] Finance lease obligations, current portion Finance Lease, Liability, Current Debt Instrument [Line Items] Debt Instrument [Line Items] Weighted-average number of shares used to compute net loss per share, basic (in shares) Weighted Average Number of Shares Outstanding, Basic Entity Current Reporting Status Entity Current Reporting Status Concentration Risk Type [Domain] Concentration Risk Type [Domain] Loss from operations Operating Income (Loss) Concentration Risk Benchmark [Axis] Concentration Risk Benchmark [Axis] Issuance of stock from vested restricted stock units and payment of employees' taxes Issuance Of Stock From Vested Restricted Stock Units And Payment Of Employees Taxes, Value Issuance Of Stock From Vested Restricted Stock Units And Payment Of Employees Taxes, Value Shipping and Handling Shipping and Handling [Member] Cost of revenue Cost of Revenue Prepaid expenses and other current assets Prepaid Expense and Other Assets Cash flows from operating activities: Net Cash Provided by (Used in) Operating Activities, Continuing Operations [Abstract] Statement [Line Items] Statement [Line Items] Vested and expected to vest, end of period (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number Stock Options, Additional Disclosures [Abstract] Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Additional Disclosures [Abstract]